Seeking Alpha

Focus Advisory » Comments » LLY

  • Lilly's Arzoxifene Defeat: Pharma Giant's Pipeline Looks Awfully Dry Now [View article]
    Lack of LLY pipleline is one reason I am buying AMLN at these levels. Will be shocked if LLY has not aquired its Byetta partner by this time next year.
    Regards
    Aug 20 15:00 pm |Rating: +1 0 |Link to Comment
More on LLY by Focus Advisory
Comments by Ticker
Focus Advisory's
Comments Stats
30 comments
Rating: 14 (23 - 9 )